NEW YORK, Dec. 8, 2021 /PRNewswire/ — CB Insights today named Theator to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. This year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.

The 2021 Digital Health 150 cohort has raised roughly $14.9B in aggregate funding across 522 deals since 2016, and includes startups at various investment stages of development, from early-stage to well-funded unicorns. Companies this year include startups working on data integration & analytics, hybrid virtual / in-person care, digital therapeutics, clinical intelligence, and more.

“This year’s Digital Health 150 is one of our most expansive yet, spotlighting 16 categories including virtual care, clinical trials tech, and workflow automation, as well as adding new categories such as home health tech and computer-aided imaging,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “Last year’s class has seen more than 20 exits, raised an additional $18.6B in aggregate funding, and announced over 250 partnerships since being recognized, and we’re excited to see the future success of this year’s winners.”

“We are singularly focused on redefining routine video capture and analysis as the new gold standard in surgical care,” said Dr. Tamir Wolf, CEO and Co-Founder of Theator. “Every unrecorded procedure is a lost opportunity to derive insights for surgeons, bolster institutional understanding for entire hospital departments and systems. Such data is crucial if we are to eliminate variability and disparity in surgical care.”